Viewing Study NCT03144856

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-02-25 @ 6:30 PM
Study NCT ID: NCT03144856
Status: UNKNOWN
Last Update Posted: 2017-05-09
First Post: 2017-05-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Biliary Tract Cancer View
None Second line thrapy View
None Apatinib View